Literature DB >> 27048942

Rational design, synthesis and 2D-QSAR study of novel vasorelaxant active benzofuran-pyridine hybrids.

Aladdin M Srour1, Somaia S Abd El-Karim2, Dalia O Saleh3, Wafaa I El-Eraky3, Zeinab M Nofal2.   

Abstract

Reaction of 3-aryl-1-(benzofuran-2-yl)-2-propen-1-ones 3a-c with malononitrile in the presence of sufficient amount of sodium alkoxide in the corresponding alcohol proceeds in a regioselective manner to afford 2-alkoxy-4-aryl-6-(benzofuran-2-yl)-3-pyridinecarbonitriles 4-37, which also obtained by treating ylidenemalononitriles 6a-q with 2-acetylbenzofuran 1 in the presence of sufficient amount of sodium alkoxide in the corresponding alcohol. The new chemical entities showed significant vasodilation properties using isolated thoracic aortic rings of rats pre-contracted with norepinephrine hydrochloride standard technique. Compounds 11, 16, 21, 24 and 30 exhibited remarkable activity compared with amiodarone hydrochloride the reference standard used in the present study. CODESSA-Pro software was employing to obtain a statistically significant QSAR model describing the bioactivity of the newly synthesized analogs (N=31, n=5, R(2)=0.846, R(2)cvOO=0.765, R(2)cvMO=0.778, F=27.540. s(2)=0.002).
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amiodarone; Benzofuran; Pyridinecarbonitrile; QSAR; Vasodilator

Mesh:

Substances:

Year:  2016        PMID: 27048942     DOI: 10.1016/j.bmcl.2016.03.054

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents.

Authors:  Dina H Dawood; Aladdin M Srour; Dalia O Saleh; Kelley J Huff; Francesca Greco; Helen M I Osborn
Journal:  RSC Adv       Date:  2021-09-02       Impact factor: 3.361

2.  Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators.

Authors:  Nagy M Khalifa; Aladdin M Srour; Somaia S Abd El-Karim; Dalia O Saleh; Mohamed A Al-Omar
Journal:  Molecules       Date:  2017-10-26       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.